These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24023969)

  • 21. Methylated and unmethylated epialleles support variegated epigenetic silencing in Friedreich ataxia.
    Rodden LN; Chutake YK; Gilliam K; Lam C; Soragni E; Hauser L; Gilliam M; Wiley G; Anderson MP; Gottesfeld JM; Lynch DR; Bidichandani SI
    Hum Mol Genet; 2021 Feb; 29(23):3818-3829. PubMed ID: 33432325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FXN Promoter Silencing in the Humanized Mouse Model of Friedreich Ataxia.
    Chutake YK; Costello WN; Lam CC; Parikh AC; Hughes TT; Michalopulos MG; Pook MA; Bidichandani SI
    PLoS One; 2015; 10(9):e0138437. PubMed ID: 26393353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia.
    Fil D; Chacko BK; Conley R; Ouyang X; Zhang J; Darley-Usmar VM; Zuberi AR; Lutz CM; Napierala M; Napierala JS
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MutLα heterodimers modify the molecular phenotype of Friedreich ataxia.
    Ezzatizadeh V; Sandi C; Sandi M; Anjomani-Virmouni S; Al-Mahdawi S; Pook MA
    PLoS One; 2014; 9(6):e100523. PubMed ID: 24971578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Comprehensive Transcriptome Analysis Identifies FXN and BDNF as Novel Targets of miRNAs in Friedreich's Ataxia Patients.
    Misiorek JO; Schreiber AM; Urbanek-Trzeciak MO; Jazurek-Ciesiołka M; Hauser LA; Lynch DR; Napierala JS; Napierala M
    Mol Neurobiol; 2020 Jun; 57(6):2639-2653. PubMed ID: 32291635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long intronic GAA*TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia.
    Soragni E; Herman D; Dent SY; Gottesfeld JM; Wells RD; Napierala M
    Nucleic Acids Res; 2008 Nov; 36(19):6056-65. PubMed ID: 18820300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FAST-1 antisense RNA epigenetically alters FXN expression.
    Mikaeili H; Sandi M; Bayot A; Al-Mahdawi S; Pook MA
    Sci Rep; 2018 Nov; 8(1):17217. PubMed ID: 30464193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanded GAA repeats impede transcription elongation through the FXN gene and induce transcriptional silencing that is restricted to the FXN locus.
    Li Y; Lu Y; Polak U; Lin K; Shen J; Farmer J; Seyer L; Bhalla AD; Rozwadowska N; Lynch DR; Butler JS; Napierala M
    Hum Mol Genet; 2015 Dec; 24(24):6932-43. PubMed ID: 26401053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of mismatch repair enzymes in GAA·TTC triplet-repeat expansion in Friedreich ataxia induced pluripotent stem cells.
    Du J; Campau E; Soragni E; Ku S; Puckett JW; Dervan PB; Gottesfeld JM
    J Biol Chem; 2012 Aug; 287(35):29861-72. PubMed ID: 22798143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation and characterization of iPSC lines from Friedreich's ataxia patient (FRDA) with GAA.TTC repeat expansion in the Frataxin (FXN) gene's first intron (IGIBi016-A) and a non-FRDA healthy control individual (IGIBi017-A).
    Ahmad I; Kamai A; Zahra S; Kapoor H; Kumar Srivastava A; Faruq M
    Stem Cell Res; 2024 Jun; 77():103382. PubMed ID: 38484450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic promoter silencing in Friedreich ataxia is dependent on repeat length.
    Chutake YK; Lam C; Costello WN; Anderson M; Bidichandani SI
    Ann Neurol; 2014 Oct; 76(4):522-8. PubMed ID: 25112975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterising the neuropathology and neurobehavioural phenotype in Friedreich ataxia: a systematic review.
    Corben LA; Georgiou-Karistianis N; Bradshaw JL; Evans-Galea MV; Churchyard AJ; Delatycki MB
    Adv Exp Med Biol; 2012; 769():169-84. PubMed ID: 23560311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Putative Epigenetic Regulatory Elements in the
    Fernández-Frías I; Pérez-Luz S; Díaz-Nido J
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32408537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype.
    Evans-Galea MV; Corben LA; Hasell J; Galea CA; Fahey MC; du Sart D; Delatycki MB
    Neurogenetics; 2011 Nov; 12(4):307-13. PubMed ID: 21830088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pitfalls in molecular diagnosis of Friedreich ataxia.
    Barcia G; Rachid M; Magen M; Assouline Z; Koenig M; Funalot B; Barnerias C; Rötig A; Munnich A; Bonnefont JP; Steffann J
    Eur J Med Genet; 2018 Aug; 61(8):455-458. PubMed ID: 29530802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models.
    Sandi C; Sandi M; Jassal H; Ezzatizadeh V; Anjomani-Virmouni S; Al-Mahdawi S; Pook MA
    PLoS One; 2014; 9(2):e89488. PubMed ID: 24586819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel frataxin isoforms may contribute to the pathological mechanism of Friedreich ataxia.
    Xia H; Cao Y; Dai X; Marelja Z; Zhou D; Mo R; Al-Mahdawi S; Pook MA; Leimkühler S; Rouault TA; Li K
    PLoS One; 2012; 7(10):e47847. PubMed ID: 23082224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia.
    Bandiera S; Cartault F; Jannot AS; Hatem E; Girard M; Rifai L; Loiseau C; Munnich A; Lyonnet S; Henrion-Caude A
    PLoS One; 2013; 8(1):e54791. PubMed ID: 23382970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic therapy for Friedreich ataxia.
    Soragni E; Miao W; Iudicello M; Jacoby D; De Mercanti S; Clerico M; Longo F; Piga A; Ku S; Campau E; Du J; Penalver P; Rai M; Madara JC; Nazor K; O'Connor M; Maximov A; Loring JF; Pandolfo M; Durelli L; Gottesfeld JM; Rusche JR
    Ann Neurol; 2014 Oct; 76(4):489-508. PubMed ID: 25159818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.
    Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E
    J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.